medigraphic.com
ISSN 1561-3011 (Electronic)

2021, Number 2

<< Back Next >>

Rev Cubana Invest Bioméd 2021; 40 (2)

Factors associated to stigma in people with tuberculosis from a high-risk region in Peru

Bonilla-Asalde CA, Rivera-Lozada IC, Rivera-Lozada O

Language: Spanish
References: 39
Page: 1-14
PDF size: 316.04 Kb.


ABSTRACT

Introduction: The stigma attached to people with tuberculosis is an important challenge posed to the control of this disease. Hence the need to know what factors trigger it, for they may affect adherence to treatment, increasing complications and mortality.
Objectives: Determine the factors associated to stigma in people with tuberculosis from a high-risk region in Peru.
Methods: A correlational study was conducted of 110 patients treated for tuberculosis. The factors analyzed were family function as gauged by the Family Apgar scale, sociodemographic and clinical characteristics, knowledge about the disease and doctor-patient communication as measured through a survey. Stigma was determined by Yang's scale. Bivariate analysis was based on the chi-square test, whereas the relationship between variables was evaluated by Pearson's correlation and multivariate linear regression.
Results: The level of stigma showed a cut off value ≥ 9 in 21.3% in sensitive tuberculosis and 69.4% in multiresistant tuberculosis, with significant differences (p = 0.000). Multivariate linear regression analysis found that a low level of knowledge about tuberculosis (ß = -0.32; p = 0.000), low scores on the Family Apgar scale (ß = -0.41; p = <0.000) and poor doctor-patient communication (ß = -0.47; p = 0.000) were negatively associated to stigma.
Conclusions: The study found a high level of stigma associated to tuberculosis, as well as a negative association between stigma and knowledge about the disease, family function and communication with the doctor.


REFERENCES

  1. World Health Organization (WHO). Global tuberculosis report 2016. World Health Organization: Geneva; 2019.

  2. World Health Organization (WHO). Tuberculosis country profiles; 2018. [acceso: 25/03/2019]. Disponible en: http://www.who.int/tb/country/data/profiles/en/

  3. World Health Organization (WHO). Tuberculosis programme: framework for effective tuberculosis control. Eur Respir J. 2002:19:590-2.

  4. Rivera O, Rivera O, Benites S, Mendigure J, Bonilla CA. Abandono terapéutico en tuberculosis multidrogorresistente: factores asociados en una región de alta carga en Perú. Biomédica. 2019 [acceso: 28/03/2020]; 39(3). Disponible en: https://www.revistabiomedica.org/index.php/biomedica/article/view/4564

  5. Farga V, Torres Z, Herrera M. Perfil del paciente con tuberculosis que abandona el tratamiento en Chile. Rev Chil Enf Respir. 2015;31:52-7. DOI: 10.4067/S0717-73482015000100008

  6. Bonilla-Asalde C, Rivera-Lozada IC, Rivera-Lozada O. Barriers to accessing health services and their association with treatment adherence in tuberculosis patients at a hospital in Peru. Pak J Med Health Sci 2020;14(3):1296-1304.

  7. Coreli J, Lauzardo M, Heurtelou M. Anticipated tuberculosis Stigma among Health Professionals and Haitian Patients in South Florida. NIH Public Access. 2012;23(3):636-50.

  8. Bonilla-Asalde C, Rivera-Lozada IC, Rivera-Lozada O. Determinants of multi-drug resistant tuberculosis treatment failure in a prevalent region in Peru. Pak J Med Health Sci 2020;14(3):1013-1018.

  9. Qiu L, Tong Y, Lu Z, Gong Y, Yin X. Depressive symptoms mediate the associations of stigma with medication adherence and quality of life in tuberculosis patients in China. Am J Trop Med Hyg. 2019;100(1):31-6.

  10. Heath K, Byard RW. Tuberculosis-related stigma contributing to a "hidden" disease at autopsy. Med Sci Law. 2019;59(3):135-8. PMID: 31081464

  11. Craig GM, Daftary A, Engel N, O'Driscoll S, Ioannaki A. Tuberculosis stigma as a social determinant of health: a systematic mapping review of research in low incidence countries. Vol. 56, International Journal of Infectious Diseases. Elsevier B.V.; 2017. p. 90-100.

  12. Cremers AL, de Laat MM, Kapata N, Gerrets R, Klipstein-Grobusch K, Grobusch MP. Assessing the consequences of stigma for tuberculosis patients in Urban Zambia. PLoS ONE 2015:10:e0119861.

  13. Wynne A, Richter S, Jhangri GS, Alibhai A, Rubaale T, Kipp W. Tuberculosis and human immunodeficiency virus: exploring stigma in a community in western Uganda. AIDS Care 2014:26:940-6.

  14. Paz-Soldan VA, Alban RE, Jones CD, Oberhelman RA. The provision of and need for social support among adult and pediatric patients with tuberculosis in Lima, Peru: a qualitative study. BMC Health Services Res. 2013:13:290.

  15. Chakrabartty A, Basu P, Ali KM. Tuberculosis related stigma and its effect on the delay for sputum examination under the Revised National Tuberculosis Control Program in India. Indian J Tuberc. 2018;65:145-51.

  16. Yang TT. Development and evaluation of tuberculosis-related stigma scale. J Pubic Health Prevent Med. 2016;27:119-22.

  17. Yin X, Yan S, Tong Y, Peng X, Yang T, Lu Z, et al. Status of tuberculosis-related stigma and associated factors: a cross-sectional study in central China. Trop Med Int Heal. 2018 [acceso: 26/03/2020]; 23(2):199-205. Disponible en: http://doi.wiley.com/10.1111/tmi.13017

  18. Smilkstein G. The family APGAR: a proposal for a family function test and its use by physicians. J Fam Pract. 1978:6:1231-9.

  19. Gallardo-Peralta LP, Barrón A, Molina MA, Schettini R. Family and community support among older Chilean adults: the importance of heterogeneous social support sources for quality of life. J Gerontol Soc Work. 2018;61(6):584-604.

  20. Ettridge K, Bowden J, Chambers S, Smith D, Murphy M, Evans S, et al. "Prostate cancer is far more hidden...": Perceptions of stigma, social isolation and help-seeking among men with prostate cancer. Eur J Cancer Care. 2018;27(2):e12790.

  21. Hofstraat K, van Brakel WH. Social stigma towards neglected tropical diseases: a systematic review. Int Health. 2016;8(Suppl 1):i53-70.

  22. Lan CW, Lin C, Thanh DC, Li L. Drug-related stigma and access to care among people who inject drugs in Vietnam. Drug Alcohol Rev. 2018;37(3):333-9.

  23. Stringer KL, Baker EH. Stigma as a barrier to substance abuse treatment among those with unmet need: an analysis of parenthood and marital status. J Fam Issues. 2018;39(1):3-27.

  24. Rueda S, Mitra S, Chen S, Gogolishvili D, Globerman J, Chambers L, et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ Open. 2016;6(7):e011453.

  25. Yang LH, Wong LY, Grivel MM, Hasin DS. Stigma and substance use disorders: an international phenomenon. Curr Opin Psychiatr. 2017;30(5):378-88.

  26. Frick M, von Delft D, Kumar B. End stigmatizing language in tuberculosis research and practice. BMJ. 2015;350:h1479. DOI: 10.1136/bmj.h1479

  27. Chung AH, Rimal RN. Revisiting the importance of knowledge: from Namibia, a case for promoting knowledge by campaigns to reduce stigma. Health Educat Behav 2015:42:249-56.

  28. Somma D, Thomas BE, Karim F, Kemp J, Arias N, Auer C, et al. Gender and socio-cultural determinants of TB-related stigma in Bangladesh, India, Malawi and Colombia. Int J Tuberculosis Lung Dis. 2008;12(7):856-66.

  29. de Almeida J, Caetano L, Yamamura M, Paschoat M, Vieira A, Henrrique L. Validez y fiabilidad de la versión de escala de estigma relacionado con la tuberculosis para el portugués brasileño. BMC Infect Dis. 2017:17:510.

  30. Hudelson P. Gender differentials in tuberculosis: the role of socio-economic and cultural factors. Tuber Lung Dis. 1996;77(5):391-400.

  31. Datiko DG, Jerene D, Suarez P. Stigma matters in ending tuberculosis: Nationwide survey of stigma in Ethiopia. BMC Public Health. 2020;20(190). DOI: 10.1186/s12889-019-7915-6

  32. Miller C, Huston J, Samu L, Mfinanga S, Hopewell P, Fair E. 'It makes the patient's spirit weaker': tuberculosis stigma and gender interaction in Dar Es Salaam, Tanzania. Int J Tuberc Lung Dis. 2017;21(11):42-8.

  33. Chowdhury MR, Rahman MS, Mondal MN, Sayem A, Billah B. Social impact of stigma regarding tuberculosis hindering adherence to treatment: a cross sectional study involving tuberculosis patients in Rajshahi City, Bangladesh. Jpn J Infect Dis. 2015;68(6):461-6.

  34. Lee L-Y, Tung H-H, Chen S-C, Fu C-H. Perceived stigma and depression in initially diagnosed pulmonary tuberculosis patients. J Clin Nurs. 2017 [acceso: 25/03/2020]; 26(23-24):4813-21. Disponible en: http://doi.wiley.com/10.1111/jocn.13837

  35. Cheng Y, Zhang L, Wang F, Zhang P, Ye B, Liang Y. The effects of family structure and function on mental health during China's transition: a cross-sectional analysis. BMC Family Pract. 2017;18:59.

  36. Tadesse S. Stigma against Tuberculosis Patients in Addis Ababa, Ethiopia. Kumar A, editor. PLoS One. 2016 [acceso: 03/04/2020]; 11(4):e0152900. Disponible en: http://dx.plos.org/10.1371/journal.pone.0152900

  37. Arulchelvan S, Elangovan R. Effective communication approaches in tuberculosis control: Health workers' perceptions and experiences. Indian J Tuberc. 2017;64(4):318-22.

  38. Chung AH, Rimal RN. Revisiting the importance of knowledge: from Namibia, a case for promoting knowledge by campaigns to reduce stigma. Health Educat Behav. 2015;42:249-56.

  39. Daftary A. HIV and tuberculosis: the construction and management of double stigma. Soc Sci Med. 2012;74(10):1512-9.




2020     |     www.medigraphic.com